Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions

Journal: Nature Medicine

Published: 2020-02-17

DOI: 10.1038/s41591-020-0770-2

Affiliations: 12

Authors: 21

Go to article
Institutions Share
Russell H. Morgan Department of Radiology and Radiological Science, JHU, United States of America (USA) 0.27
Center for Translational Medicine (CTM), UMB, United States of America (USA) 0.14
Center for Tuberculosis Research Laboratory, JHU, United States of America (USA) 0.12
Center for Infection and Inflammation Imaging Research, JHU, United States of America (USA) 0.10
Baylor Institute for Immunology Research (BIIR), United States of America (USA) 0.07
Texas Tech University Health Sciences Center (TTUHSC), United States of America (USA) 0.07
Department of Medicine, JHU, United States of America (USA) 0.05
Vaccine and Infectious Disease Division (VIDD), FHCRC, United States of America (USA) 0.05
Johns Hopkins Children’s Center, United States of America (USA) 0.04
Department of Anesthesiology and Critical Care Medicine, JHU, United States of America (USA) 0.03
Department of Pharmacotherapy and Translational Research, UF, United States of America (USA) 0.02
Infectious Disease Pharmacokinetics Laboratory (IDPL), UF, United States of America (USA) 0.02

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER